Annual Revenue
$194.75 M
+$70.95 M+57.31%
December 31, 2021
Summary
- As of February 10, 2025, GBT annual revenue is $194.75 million, with the most recent change of +$70.95 million (+57.31%) on December 31, 2021.
Performance
GBT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
$71.55 M
+$16.39 M+29.71%
June 30, 2022
Summary
- As of February 10, 2025, GBT quarterly revenue is $71.55 million, with the most recent change of +$16.39 million (+29.71%) on June 30, 2022.
- Over the past year, GBT quarterly revenue has increased by +$24.00 million (+50.46%).
Performance
GBT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$234.86 M
+$24.00 M+11.38%
June 30, 2022
Summary
- As of February 10, 2025, GBT TTM revenue is $234.86 million, with the most recent change of +$24.00 million (+11.38%) on June 30, 2022.
- Over the past year, GBT TTM revenue has increased by +$70.08 million (+42.53%).
Performance
GBT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
GBT Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +57.3% | +50.5% | +42.5% |
3 y3 years | - | - | +10000.0% |
5 y5 years | - | - | +10000.0% |
GBT Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | at high | -22.9% | at high | -17.1% |
5 y | 5-year | at high | -98.9% | at high | -97.1% | at high | -99.1% |
alltime | all time | at high | -98.9% | at high | -97.1% | at high | -99.1% |
Global Blood Therapeutics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | $71.55 M(+29.7%) | $234.86 M(+11.4%) |
Mar 2022 | - | $55.16 M(-1.7%) | $210.87 M(+8.3%) |
Dec 2021 | $194.75 M | $56.10 M(+7.8%) | $194.75 M(+8.2%) |
Sep 2021 | - | $52.05 M(+9.5%) | $179.94 M(+9.2%) |
Jun 2021 | - | $47.55 M(+21.8%) | $164.78 M(+10.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $39.04 M(-5.5%) | $148.73 M(+20.1%) |
Dec 2020 | $123.80 M(+5773.0%) | $41.30 M(+11.9%) | $123.80 M(+46.3%) |
Sep 2020 | - | $36.89 M(+17.1%) | $84.62 M(+77.3%) |
Jun 2020 | - | $31.50 M(+123.1%) | $47.73 M(+194.1%) |
Mar 2020 | - | $14.12 M(+569.7%) | $16.23 M(+669.7%) |
Dec 2019 | $2.11 M | $2.11 M | $2.11 M |
FAQ
- What is Global Blood Therapeutics annual revenue?
- What is the all time high annual revenue for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual revenue year-on-year change?
- What is Global Blood Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly revenue year-on-year change?
- What is Global Blood Therapeutics TTM revenue?
- What is the all time high TTM revenue for Global Blood Therapeutics?
- What is Global Blood Therapeutics TTM revenue year-on-year change?
What is Global Blood Therapeutics annual revenue?
The current annual revenue of GBT is $194.75 M
What is the all time high annual revenue for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual revenue is $194.75 M
What is Global Blood Therapeutics annual revenue year-on-year change?
Over the past year, GBT annual revenue has changed by +$70.95 M (+57.31%)
What is Global Blood Therapeutics quarterly revenue?
The current quarterly revenue of GBT is $71.55 M
What is the all time high quarterly revenue for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly revenue is $71.55 M
What is Global Blood Therapeutics quarterly revenue year-on-year change?
Over the past year, GBT quarterly revenue has changed by +$24.00 M (+50.46%)
What is Global Blood Therapeutics TTM revenue?
The current TTM revenue of GBT is $234.86 M
What is the all time high TTM revenue for Global Blood Therapeutics?
Global Blood Therapeutics all-time high TTM revenue is $234.86 M
What is Global Blood Therapeutics TTM revenue year-on-year change?
Over the past year, GBT TTM revenue has changed by +$70.08 M (+42.53%)